{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:25:26Z","timestamp":1789503926348,"version":"build-2803163510"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Acute chest syndrome (ACS) is a life-threatening complication of sickle cell anemia (SCA). Most often, ACS occurs during the progression of a painful vaso-occlusive crisis (VOC) in vulnerable patients. The present study aimed to identify early risk factors for ACS progression, focusing on patient assessments in a pediatric Emergency Department. In this study (2016\u20132022) concerning exclusively the SS and S\u03b2\n                    <jats:sup>0<\/jats:sup>\n                    sickle cell disease genotypes, severe VOC encounters progressing to ACS were compared to uncomplicated severe VOCs. Medical history, clinical and laboratory data were collected for both groups. Out of 280 severe VOC encounters without initial respiratory symptoms, 40 progressed to life-threatening acute chest syndrome. The forty ACS (age 8.5\u2009\u00b1\u20094.3 years, 37% females) were compared with 240 severe VOCs (9.3\u2009\u00b1\u20094.4 years, 46% females). ACS was positively correlated with the occurrence of VOC at night, diffuse (multifocal) pain and increased C-Reactive protein (p\u2009&lt;\u20090.05). The multivariable modelling, using generalized linear mixed-effects models, defined three risk factors for ACS occurrence: diffuse pain, night-time pain occurrence, and increased C-Reactive protein (p\u2009&lt;\u20090.01). Increased use of opiates in the Emergency Department, elevated total leucocyte count, breath rate, and decreased red blood cell count were not significantly associated with ACS occurrence (p\u2009&gt;\u20090.05). The initial evaluation of SCA patients\u2019 acute pain in the Emergency Department is crucial for subsequent management during hospitalization.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0336567","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T18:25:04Z","timestamp":1763144704000},"page":"e0336567","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Early risk factors for acute chest syndrome in sickle cell anemia: A pediatric study"],"prefix":"10.1371","volume":"20","author":[{"given":"Mohamed","family":"Cond\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florie","family":"Bouvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roselyne","family":"Brat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Ferrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Hankard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Connes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5852-7624","authenticated-orcid":true,"given":"Georges","family":"Dimitrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"pone.0336567.ref001","doi-asserted-by":"crossref","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"GJ Kato","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"pone.0336567.ref002","article-title":"Global burden of sickle cell anaemia in children under five, 2010\u20132050: modelling based on demographics, excess mortality, and interventions","volume":"10","author":"FB Piel","year":"2013","journal-title":"PLoS Med"},{"issue":"16","key":"pone.0336567.ref003","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle Cell Disease","volume":"376","author":"FB Piel","year":"2017","journal-title":"N Engl J Med"},{"issue":"10091","key":"pone.0336567.ref004","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","article-title":"Sickle cell disease","volume":"390","author":"RE Ware","year":"2017","journal-title":"Lancet"},{"issue":"7","key":"pone.0336567.ref005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253986","article-title":"Epidemiology and disease burden of sickle cell disease in France: A descriptive study based on a French nationwide claim database","volume":"16","author":"H Leleu","year":"2021","journal-title":"PLoS One"},{"issue":"9","key":"pone.0336567.ref006","first-page":"2476","article-title":"Severity and burden of sickle cell disease in France: a nationwide real-world study","volume":"108","author":"V Brousse","year":"2023","journal-title":"Haematologica"},{"issue":"9","key":"pone.0336567.ref007","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/pbc.24557","article-title":"Sickle cell disease related mortality in the United States (1999-2009)","volume":"60","author":"D Hamideh","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"pone.0336567.ref008","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.15374","article-title":"Estimated life expectancy and income of patients with sickle cell disease compared with those without sickle cell disease","volume":"2","author":"D Lubeck","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"3","key":"pone.0336567.ref009","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/ejh.13430","article-title":"The vaso-occlusive pain crisis in sickle cell disease: Definition, pathophysiology, and management","volume":"105","author":"DS Darbari","year":"2020","journal-title":"Eur J Haematol"},{"issue":"1","key":"pone.0336567.ref010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ajh.21550","article-title":"Definitions of the phenotypic manifestations of sickle cell disease","volume":"85","author":"SK Ballas","year":"2010","journal-title":"Am J Hematol"},{"issue":"2","key":"pone.0336567.ref011","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/bloodadvances.2019001143","article-title":"American Society of Hematology 2020 Guidelines for Sickle Cell Disease: Transfusion Support","volume":"4","author":"ST Chou","year":"2020","journal-title":"Blood Advances"},{"key":"pone.0336567.ref012","author":"World Health Organisation"},{"key":"pone.0336567.ref013","volume-title":"Major sickle cell syndromes in children and adolescents","author":"French National Diagnostic and Care Protocol","year":"2024"},{"issue":"8","key":"pone.0336567.ref014","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.pain.2012.02.024","article-title":"EVENDOL, a new behavioral pain scale for children ages 0 to 7 years in the emergency department: design and validation","volume":"153","author":"E Fournier-Charri\u00e8re","year":"2012","journal-title":"Pain"},{"issue":"1","key":"pone.0336567.ref015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/MPH.0000000000001012","article-title":"Recurrent Acute Chest Syndrome in Pediatric Sickle Cell Disease: Clinical Features and Risk Factors","volume":"40","author":"GD Patterson","year":"2018","journal-title":"J Pediatr Hematol Oncol"},{"key":"pone.0336567.ref016","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ebiom.2016.06.038","article-title":"Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients","volume":"10","author":"P Bartolucci","year":"2016","journal-title":"EBioMedicine"},{"issue":"3","key":"pone.0336567.ref017","article-title":"Acute chest syndrome, airway inflammation and lung function in sickle cell disease","volume":"18","author":"A De","year":"2023","journal-title":"PLOS ONE"},{"issue":"6","key":"pone.0336567.ref018","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/bjh.14896","article-title":"Inflammatory mediators in sickle cell anaemia highlight the difference between steady state and crisis in paediatric patients","volume":"182","author":"MOS Carvalho","year":"2018","journal-title":"Br J Haematol"},{"issue":"1","key":"pone.0336567.ref019","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1038\/s41598-023-48527-1","article-title":"Risk factors for acute chest syndrome among children with sickle cell anemia hospitalized for vaso-occlusive crises","volume":"14","author":"FA Alghamdi","year":"2024","journal-title":"Sci Rep"},{"issue":"11","key":"pone.0336567.ref020","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.23819","article-title":"Factors predicting future ACS episodes in children with sickle cell anemia","volume":"89","author":"MR DeBaun","year":"2014","journal-title":"Am J Hematol"},{"issue":"8","key":"pone.0336567.ref021","doi-asserted-by":"crossref","DOI":"10.1097\/MPH.0000000000001467","article-title":"Nucleated Red Blood Cells in Children With Sickle Cell Disease Hospitalized for Pain","volume":"41","author":"JD Ballantine","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"issue":"10","key":"pone.0336567.ref022","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.26286","article-title":"Real-life experience with hydroxyurea in patients with sickle cell disease: results from the prospective ESCORT-HU cohort study","volume":"96","author":"M de Montalembert","year":"2021","journal-title":"Am J Hematol"},{"issue":"6","key":"pone.0336567.ref023","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30294","article-title":"Efficacy and safety of pharmacological interventions for managing sickle cell disease complications in children and adolescents: Systematic review with network meta-analysis","volume":"70","author":"FS Tonin","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"pone.0336567.ref024","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1542\/peds.2008-0441","article-title":"Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children","volume":"122","author":"JJ Strouse","year":"2008","journal-title":"Pediatrics"},{"issue":"3","key":"pone.0336567.ref025","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jpeds.2009.09.044","article-title":"Adherence to hydroxyurea therapy in children with sickle cell anemia","volume":"156","author":"CD Thornburg","year":"2010","journal-title":"J Pediatr"},{"issue":"6","key":"pone.0336567.ref026","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1542\/peds.2014-0177","article-title":"Medication adherence among pediatric patients with sickle cell disease: a systematic review","volume":"134","author":"KE Walsh","year":"2014","journal-title":"Pediatrics"},{"issue":"6","key":"pone.0336567.ref027","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29607","article-title":"Impact of hydroxyurea dose and adherence on hematologic outcomes for children with sickle cell anemia","volume":"69","author":"SE Creary","year":"2022","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"pone.0336567.ref028","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30878","article-title":"Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment (HABIT) efficacy trial: Community health worker support may increase hydroxyurea adherence of youth with sickle cell disease","volume":"71","author":"NS Green","year":"2024","journal-title":"Pediatr Blood Cancer"},{"issue":"23","key":"pone.0336567.ref029","doi-asserted-by":"crossref","first-page":"7190","DOI":"10.1182\/bloodadvances.2023010670","article-title":"A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell disease","volume":"7","author":"JS Hankins","year":"2023","journal-title":"Blood Advances"},{"issue":"6","key":"pone.0336567.ref030","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.jaci.2010.12.1114","article-title":"Elevation of IgE in children with sickle cell disease is associated with doctor diagnosis of asthma and increased morbidity","volume":"127","author":"P An","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"pone.0336567.ref031","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1182\/blood-2006-01-011072","article-title":"Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia","volume":"108","author":"JH Boyd","year":"2006","journal-title":"Blood"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0336567","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T18:25:10Z","timestamp":1763144710000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0336567"}},"subtitle":[],"editor":[{"given":"Deogratias","family":"Munube","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":31,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0336567","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]}}}